Structural and Functional Evaluation of Coronary Arteries Treated With ABSORB Bioresorbable Vascular Scaffold at 5-Year Follow-Up

被引:2
作者
Renier Goncalves-Ramirez, Luis [1 ,2 ]
Amat-Santos, Ignacio J. [1 ]
Abdul-Jawad Altisent, Omar [3 ]
Gutierrez, Hipolito [1 ]
Perez de Prado, Armando [2 ]
Adelino, Raquel [3 ]
Gomez, Itziar [1 ]
Fernandez-Vazquez, Felipe [2 ]
San Roman, Alberto [1 ]
Puri, Rishi [4 ]
机构
[1] Hosp Clin Univ, CIBERCV, Valladolid, Spain
[2] Complejo Asistencial Univ Leon CAULE, Leon, Spain
[3] Germans Trias & Pujol Univ Hosp, CIBERCV, Badalona, Spain
[4] Cleveland Clin, Cleveland, OH 44106 USA
关键词
OPTICAL COHERENCE TOMOGRAPHY; 2-YEAR OUTCOMES; INTERVENTION; DISEASE; STENT;
D O I
10.1016/j.amjcard.2022.07.038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although complete bioresorbable vascular scaffold (BVS) resorption has been demon-strated at 5-year follow-up, whether corresponding vasomotor function restoration occurs remains unknown. The objective was to simultaneously assess the structural healing response along with vasomotor responses at 5-year follow-up of BVS implantation. We studied consecutive patients treated with ABSORB-BVS at 5-year follow-up (n = 31), who were recruited from a multicenter registry and were contacted to undergo a research pro-tocol-driven repeat coronary angiogram involving intracoronary optical coherence tomog-raphy (OCT) and invasive coronary endothelial function testing. Epicardial endothelium -dependent vasomotion was defined as any vasodilatation after intracoronary acetylcholine (ACh), whereas endothelium-independent vasomotion was defined as any vasodilatation after intracoronary nitroglycerine (NTG), using quantitative coronary angiography. The mean implantation time point was 60.5 +/- 4.6 months. OCT imaging demonstrated com-plete scaffold resorption in all patients. New coronary lesions (stenosis >50%) were found in 5 patients (16.1%), 3 of them underwent ad hoc percutaneous revascularization (9.7%). Intracoronary ACh (27 patients) and NTG testing (30 patients) was performed. Quantita-tive coronary angiography analysis demonstrated vasoconstriction after ACh administra-tion and lack of response to NTG in BVS segments (mean lumen diameter = 2.00 +/- 0.61 mm at baseline vs 1.74 +/- 0.70 mm post-ACh, p <0.001; 2.05 +/- 0.54 mm at baseline vs 2.03 +/- 0.50 mm post-NTG, p = 0.69). OCT lumen analysis demonstrated similar vasocon-strictive responses to ACh (mean lumen area = 5.31 +/- 2.26 mm2 at baseline vs 5.12 +/- 2.55 mm2 post-ACh, p = 0.007) but had a vasodilatory response to NTG (5.96 +/- 2.35 mm2 at baseline vs 6.17 +/- 2.55 mm2 post-NTG, p<0.001). In conclusion, complete ABSORB-BVS resorption was demonstrated at 5-year follow-up. However, this healing response was associated with endothelium-dependent vasomotor dysfunction within the BVS seg-ment. (c) 2022 Elsevier Inc. All rights reserved. (Am J Cardiol 2022;182:1-7)
引用
收藏
页码:1 / 7
页数:7
相关论文
共 24 条
[1]   Intracoronary optical coherence tomography: state of the art and future directions [J].
Ali, Ziad A. ;
Galougahi, Keyvan Karimi ;
Mintz, Gary S. ;
Maehara, Akiko ;
Shlofmitz, Richard A. ;
Mattesini, Alessio .
EUROINTERVENTION, 2021, 17 (02) :E105-+
[2]   Covering our tracks - optical coherence tomography to assess vascular healing [J].
Ali, Ziad A. ;
Galougahi, Keyvan Karimi ;
Finn, Aloke V. .
EUROINTERVENTION, 2018, 14 (12) :E1247-E1251
[3]   2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy [J].
Ali, Ziad A. ;
Serruys, Patrick W. ;
Kimura, Takeshi ;
Gao, Runlin ;
Ellis, Stephen G. ;
Kereiakes, Dean J. ;
Onuma, Yoshinobu ;
Simonton, Charles ;
Zhang, Zhen ;
Stone, Gregg W. .
LANCET, 2017, 390 (10096) :760-772
[4]   Long-Term Intracoronary Structural and Vasomotor Assessment of the ABSORB Bioresorbable Vascular Scaffold [J].
Altisent, Omar Abdul-Jawad ;
Renier Goncalves-Ramirez, Luis ;
Fernandez, Leticia ;
Vilades, David ;
Gutierrez, Enrique ;
Mitomo, Satoru ;
Latib, Azeem ;
Gabriel Cordoba-Soriano, Juan ;
Adelino, Raquel ;
Amat-Santos, Ignacio ;
Francisco Munoz, Juan ;
Elizaga, Jaime ;
Bezzera, Hiram ;
Rodrigues Pereira, Gabriel Tensol ;
Perez de Prado, Armando ;
Carrillo, Xavier ;
Fernandez-Nofrerias, Eduard ;
Vilalta, Victoria ;
Rodriguez-Leor, Oriol ;
Llibre, Cinta ;
Fadeuilhe, Edgar ;
Trujillo, Aaron ;
Mauri, Josepa ;
de la Torre Hernandez, Jose M. ;
Bayes-Genis, Antoni ;
Puri, Rishi .
AMERICAN JOURNAL OF CARDIOLOGY, 2022, 168 :55-63
[5]   Outcomes with bioabsorbable vascular scaffolds versus everolimus eluting stents Insights from randomized trials [J].
Bangalore, Sripal ;
Toklu, Bora ;
Bhatt, Deepak L. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 212 :214-222
[6]   Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary [J].
Byrne, Robert A. ;
Stefanini, Giulio G. ;
Capodanno, Davide ;
Onuma, Yoshinobu ;
Baumbach, Andreas ;
Escaned, Javier ;
Haude, Michael ;
James, Stefan ;
Joner, Michael ;
Juni, Peter ;
Kastrati, Adnan ;
Oktay, Semih ;
Wijns, William ;
Serruys, Patrick W. ;
Windecker, Stephan .
EUROINTERVENTION, 2018, 13 (13) :1574-1586
[7]   Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry [J].
Capodanno, Davide ;
Gori, Tommaso ;
Nef, Holger ;
Latib, Azeem ;
Mehilli, Julinda ;
Lesiak, Maciej ;
Caramanno, Giuseppe ;
Naber, Christoph ;
Di Mario, Carlo ;
Colombo, Antonio ;
Capranzano, Piera ;
Wiebe, Jens ;
Araszkiewicz, Aleksander ;
Geraci, Salvatore ;
Pyxaras, Stelios ;
Mattesini, Alessio ;
Naganuma, Toru ;
Muenzel, Thomas ;
Tamburino, Corrado .
EUROINTERVENTION, 2015, 10 (10) :1144-1153
[8]   Device specificity of vascular healing following implantation of bioresorbable vascular scaffolds and bioabsorbable polymer metallic drug-eluting stents in human coronary arteries: the ESTROFA OCT BVS vs. BP-DES study [J].
de la Torre Hernandez, Jose M. ;
Gonzalo, Nieves ;
Otaegui, Imanol ;
Rumoroso, Jose R. ;
Gutierrez, Hipolito ;
Alfonso, Fernando ;
Marti, Gerard ;
Serrador Frutos, Ana ;
Brugaletta, Salvatore ;
Gomez Menchero, Antonio ;
Garcia Camarero, Tamara ;
Biagioni, Corina ;
Escaned, Javier .
EUROINTERVENTION, 2018, 14 (12) :E1295-E1303
[9]   Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease [J].
Ellis, Stephen G. ;
Kereiakes, Dean J. ;
Metzger, D. Christopher ;
Caputo, Ronald P. ;
Rizik, David G. ;
Teirstein, Paul S. ;
Litt, Marc R. ;
Kini, Annapoorna ;
Kabour, Ameer ;
Marx, Steven O. ;
Popma, Jeffrey J. ;
McGreevy, Robert ;
Zhang, Zhen ;
Simonton, Charles ;
Stone, Gregg W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (20) :1905-1915
[10]   Long-Term Coronary Functional Assessment of the Infarct-Related Artery Treated With Everolimus-Eluting Bioresorbable Scaffolds or Everolimus-Eluting Metallic Stents Insights of the TROFI II Trial [J].
Gomez-Lara, Josep ;
Brugaletta, Salvatore ;
Ortega-Paz, Luis ;
Vandeloo, Bert ;
Moscarella, Elisabetta ;
Salas, Miguel ;
Romaguera, Rafael ;
Roura, Gerard ;
Ferreiro, Jose L. ;
Teruel, Luis ;
Gracida, Montserrat ;
Windecker, Stephan ;
Serruys, Patrick W. ;
Gomez-Hospital, Joan-Antoni ;
Sabate, Manel ;
Cequier, Angel .
JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (16) :1559-1571